Skip to main content

Articles

  • A REVIEW ON THE BIOLOGICAL ACTIVITIES OF 1,3,4- OXADIAZOLE

    About Author:
    Alex Martin
    Department of Pharmaceutical Chemistry,
    St. Joseph’s College of Pharmacy
    University of Health Sciences, Cherthala-688524 (Kerala), India.
    aalexmartin@rediffmail.com

    Abstract
    Oxadiazole is a five membered heterocyclic ring which is a versatile lead compound for designing potent bioactive agents. It exists in four isomeric forms. One of its four isomers 1,3,4-oxadiazole exhibited  a wide range of biological activities which includes anti-bacterial, anti-tubercular, anticonvulsant, hypoglycemic, anti-allergic, enzyme inhibitor, vasodilatory, antifungal, cytotoxic, anti-inflammatory, analgesic, hypolipidemic,  anticancer, insecticidal activities etc. The present review has basic information about 1,3,4-oxadiazole and its biological activities.

    Oxadiazoles is a heterocyclic ring and is considered to be derived from furan by the replacement of two methane (-CH=) groups by two nitrogen (-N=) atoms. There are four possible isomers of Oxadiazole, depending on the positions of hetero atoms  and they are named as 1,2,3; 1,2,4; 1,2,5; 1,3,4-oxadiazoles. 1,2,4-Oxadiazole, 1,2,5-Oxadiazole, and 1,3,4-Oxadiazole are known, but the 1,2,3-isomer is unstable and reverts to the diazoketone tautomer. The stable oxadiazoles appear in a variety of pharmaceutical drugs including raltegravir, butalamine, fasiplon,  oxolamine, and pleconaril.

  • COLON TARGETED DRUG DELIVERY SYSTEMS: A REVIEW

    ABOUT AUTHORS:
    P.Ramaa Bharathi*, Dr A.M.S.Shdhakar Babu
    Department of Pharmaceutics,
    A.M.Reddy Memorial College of pharmacy, Narasaraopet,
    Guntur (Dt), Andhra Pradesh, India.
    *puluguramabharathi63@gmail.com

  • PREPARATION AND CHARACTERIZATION OF NAPROXEN SODIUM AGGLOMERATES BY SPHERICAL CRYSTALLIZATION TECHNIQUE

    About Authors:
    Akash M Patel*, Jitul B Patel
    *Faculty of Pharmacy, Dharmsinh Desai University,
    Nadiad-387001, Gujarat
    *aku.pharmacy@gmail.com

  • PREPARATION AND CHARACTERIZATON OF ACECLOFENAC LOADED TOPICAL EMULGEL

    ABOUT AUTHORS:
    Sharma Devendra L.*1, Dr. A.K.Seth1, Nirmal Shah1, Sachinkumar P Chauhan, Chintan Aundhia
    1Department of Pharmacy, Sumandeep Vidyapeeth University,
    At & Po Pipariya, Ta.- Waghodia, Dist. Vadodara-391760.
    (Gujarat) India
    *9009dev@gmail.com

  • DEVELOPMENT AND METHOD VALIDATION OF BACLOFEN BY RP-HPLC IN BULK DRUG AND PHARMACEUTICAL FORMULATION

    ABOUT AUTHORS:
    *Kamaldeep singh, Gurvinder Pal Singh, Sandeep Kumar Sharma
    Adesh Polytechnic College,
    Sri Muktsar Sahib 152026 (Punjab)
    *kamalmehta86@yahoo.com

  • NIOSOMES- AS NOVEL DRUG DELIVERY SYSTEM

    ABOUT AUTHOR:
    Deepika Kadodiya
    Mahakal Institute Of Pharmaceutical Studies,
    Ujjain M.P.
    deepikakadodiya05@gmail.com

  • CARCINOGENICITY TESTING

    ABOUT AUTHOR:
    Jitendra kumar
    M.S. Pharmacology & Toxicology
    NIPER raebareli
    jkumar.kumar382@gmail.com

    INTRODUCTION
    This chapter presents an historical overview of cancer, carcinogenicity testing, and human cancer causes. Cancer has been known for a very long time, but the awareness of human carcinogenicity caused by chemicals is a phenomenon of the 20th century. This in turn has produced legislation that prohibits the use of carcinogens in the food chain and has provided guidelines for carcinogenicity testing in animals. Lifetime studies (18–24 months) in two main rodent species (rat and mouse), also known as the “Standard Chronic Bioassay,” have been conducted since the 1960s

  • CERVICAL CANCER VACCINE- A REVIEW

    ABOUT AUTHOR:
    Mamta Yadav
    M.Pharm
    Sagar Institute of Research Technical And Science-pharmacy
    Bhopal (M.P)
    mamtayadav811@gmail.com

  • BIPOLAR DISORDER – AN OVERVIEW

    About Authors:
    Dipal Patel*1, Dr. Kamal Singh Rathore1, Twinkal Patel2
    Department of Pharmacology
    1B.N. Institute of Pharmaceutical Science, Udaipur (Rajasthan), 313001
    2Shri Sarvajanik college of Pharmacy, Mehsana (Gujarat).
    *dipalpatel786@gmail.com

  • PHYTOTHERAPY OF CANCER - A BRIEF OVERVIEW

    About Author:
    Mridula Jayaraman,
    Amity Institute of Pharmacy,
    Amity University, India
    mridulajayaraman1990@gmail.com

    Abstract
    The word ‘cancer’ itself sends chills down our spines as its prognosis and treatment, even if detected at an early stage is cumbersome and tortuous. With the advent of modern medicines, even though it is claimed that cancer is curable, there exists virtually no chemotherapeutic agent for cancer without side effect(s), not to mention the cost of these medicines which are skyrocketing.
    Hence, we are left with little choice but to go for new fronts in research on the therapeutic agents present in plants (Phytotherapy), which are not only cost effective but also relatively side effects free.  These plants are available in plenty in the Himalayan and Aravali Region of India.  
    University
    of Wisconsin lists 150 plants which they have established as having potential value in the treatment of cancer.  However, the real issue here is that not many drugs derived from plants have been standardized and standardization of these plants for therapeutic purpose is still in the nascent stage.

Subscribe to Articles